SavedAdd your journal

Journals / Batı Karadeniz Tıp Dergisi / 2026 / Cilt: 4 Sayı: 1

The Effects of Insulin Therapy on Fetuin-A Levels in Type-2 Diabetic Patients

Tip-2 Diyabetik Hastalarda İnsulin Kullanımının Fetuin-A Düzeyi Üzerine Etkileri

Muslih Ürün(Eskişehir Şehir Hastanesi)0000-0002-9883-3398
Yonca Yılmaz Ürün(ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-6686-0300
Birsen Sahip(ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-5375-6432
Utku Şentosun(ZONGULDAK BÜLENT ECEVİT ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-7715-9576
Namık Yiğit(İSTANBUL HASEKİ EĞİTİM VE ARAŞTIRMA HASTANESİ)0000-0002-4635-4889
Pages
29–33
Publication Date
2020-04-30
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Aim: Fetuin-A is a natural inhibitor of tyrosine kinase activity and autophosphorylation of the

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Fetuin-A is a natural inhibitor of tyrosine kinase activity and autophosphorylation of the
📊
Key Findings & Data:Aim: Fetuin-A is a natural inhibitor of tyrosine kinase activity and autophosphorylation of the
💡
Conclusion & Impact:Aim: Fetuin-A is a natural inhibitor of tyrosine kinase activity and autophosphorylation of the
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Fetuin-A · Oral Antidiabetic agents · Insulin

Abstract

Aim: Fetuin-A is a natural inhibitor of tyrosine kinase activity and autophosphorylation of the

Özet

Amaç: Fetuin-A insülin reseptörünün otofosforilasyonunun ve tirozin kinaz aktivitesinin doğal bir inhibitörüdür. Fetuin-A’nın

🔖

Cite This Article

Ürün, M., Ürün, Y. Y., Sahip, B., Şentosun, U., Yiğit, N. (2020). The Effects of Insulin Therapy on Fetuin-A Levels in Type-2 Diabetic Patients. Batı Karadeniz Tıp Dergisi, Cilt: 4 Sayı: 1, 29–33. https://ajindex.com/articles/1374512

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Referans1: Satman I, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. TURDEP-II Study Group. Eur J Epidemiol. 2013 Feb;28(2):169-80.
  2. Referans2: Auberger P, et al.; Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity. Cell. 1989;58:631–640.
  3. Referans3: Mathews ST, et al Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes. 2002;51:2450–2458.
  4. Referans4: Ix JH, et al. Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation. 2006;113:1760-67.
  5. Referans5: Song A, et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. PLoS One. 2011;6(4): e19228.
  6. Referans6: Stefan N, et al. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008;57(10);2762-7.
  7. Referans7: Yilmaz Y, et al. Serum fetuin-A/a2HS-glycoprotein levels in patients with non-alcoholic fatty liver disease: relation with liver fibrosis. Ann Clin Biochem. 2010;47:549–553.
  8. Referans8: Huang Y, et al.Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article. Medicine (Baltimore). 2015 Sep;94(39):e1517.
  9. Referans9: Ou HY, et al. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly-diagnosed type 2 diabetes. Clin Endocrinol(oxf) 2011 Oct;75(4):450-5.